Opportunity ID: 57085

General Information

Document Type: Grants Notice
Funding Opportunity Number: W81XWH-10-LCRP-LCEDCC
Funding Opportunity Title: DOD Lung Cancer Early Detection Clinical Consortium Award
Opportunity Category: Discretionary
Opportunity Category Explanation: CategoryExplanation
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Science and Technology and other Research and Development
Category Explanation:
Expected Number of Awards: 1
Assistance Listings: 12.420 — Military Medical Research and Development
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Sep 03, 2010
Last Updated Date:
Original Closing Date for Applications: Dec 07, 2010
Current Closing Date for Applications: Dec 07, 2010
Archive Date: Jan 06, 2011
Estimated Total Program Funding: $13,500,000
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility”
Additional Information on Eligibility:

Additional Information

Agency Name: Dept. of the Army — USAMRAA
Description: The LCRP Early Detection Clinical Consortium Award mechanism is being offered for the first time in Fiscal Year 2010. The intent of the award is to fund clinical studies focused on characterizing, developing, and/or improving early detection modalities for lung cancer. The award is designed to bring together populations of military beneficiaries at high risk for developing lung cancer and lung cancer patients from the specified military treatment facilities (MTFs) listed in Section B.2 with the patient populations and research expertise of highly qualified civilian scientists at outstanding organizations. At the time of award completion, it is anticipated that the recipient will have established a strong infrastructure for an early detection program in order to continue clinical studies that will lead to improved patient outcomes.
Projects should be militarily relevant, have well defined objectives, should control for confounders, have a patient population that will provide a sample size of sufficient statistical power, and be capable of producing results that are likely to change clinical practice for early detection of lung cancer. Studies involving non-military patient populations must describe how they pertain to the targeted population (i.e. Armed Forces and/or the US veteran population). Studies proposed for this multi-institutional consortium effort can include small randomized or pilot clinical trials as well as large, randomized clinical trials. All projects shall be limited to clinical research and clinical trials. Animal studies are excluded from consideration.
Link to Additional Information:
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

PA HELP: 301-619-7079; cdmrp.pa@amedd.army.mil

eReceipt HELP: 301-682-5507; help@cdmrp.org

Email:cdmrp.pa@amedd.army.mil

Version History

Version Modification Description Updated Date

Folder 57085 Full Announcement-2 -> fy10 cdmrp detailed budget and justification form-1.pdf

Folder 57085 Full Announcement-2 -> fy10 cdmrp biosketch-2.pdf

Folder 57085 Full Announcement-2 -> lcrp_fy10 edcc pa_gg.pdf

Packages

Agency Contact Information: PA HELP: 301-619-7079; cdmrp.pa@amedd.army.mil
eReceipt HELP: 301-682-5507; help@cdmrp.org

Email: cdmrp.pa@amedd.army.mil

Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
12.420 PKG00020845 Sep 03, 2010 Dec 07, 2010 View

Package 1

Mandatory forms

57085 RR_SF424_1_2-1.2.pdf

57085 PerformanceSite_1_4-1.4.pdf

57085 RR_KeyPersonExpanded_1_2-1.2.pdf

2025-07-12T06:39:57-05:00

Share This Post, Choose Your Platform!

About the Author: